- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Volume 2012 (2012), Article ID 374168, 2 pages
Pediatric Metabolic Syndrome: From Prevention to Treatment
1Pediatrics Department, Child Growth and Development Research Center, Isfahan University of Medical Sciences, 81676-36954 Isfahan, Iran
2Environmental Engineering Department, Environment Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
3Preventive Cardiology Department, Children's Hospital Boston, Boston, MA, USA
4Arteriosklerose-Präventions-Institut, University of Munich, Munich, Germany
5Clinical Biochemistry, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
6Cardiology Department, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
7Nemours Cardiac Center, Alfred I. DuPont Children’s Hospital and Thomas Jefferson University, Wilmington, DE, USA
Received 8 October 2012; Accepted 8 October 2012
Copyright © 2012 Roya Kelishadi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Pediatric metabolic syndrome is becoming a substantial health problem at global level [1, 2]. It has a complex multifactorial etiology. Prevention and control of its modifiable risk factors from prenatal period can have long-term health effect on primordial prevention of chronic noncommunicable diseases. Given the increasing evidence on tracking of risk factors from childhood into adult life, the potential role of genetic, prenatal, environmental, biological, and behavioral determinants of pediatric metabolic syndrome should be underscored [3–5].
Pediatric metabolic syndrome is mainly related to “globesity,” a term used by the World Health Organization to focus on the escalating global epidemic of overweight and obesity . Although most cases are secondary to obesity, actually a substantial number of normal-weight children and adolescents have at least some components of this syndrome . The environmental factors, gene-gene, and gene-environment interactions should be considered in this context.
A growing body of evidence proposes that nonalcoholic fatty liver disease (NAFLD) and pediatric metabolic syndrome are interrelated and have common pathophysiological features [8–10]. The “two-hit hypothesis” is the most widely accepted model explaining the progression of NAFLD , and may also have a role in the development of the metabolic syndrome. Oxidative stress and proinflammatory cytokines are of the main factors initiating the second hit; the association of environmental influences on these factors, even in the pediatric age group [12–14].
The other aspect of the influences of environmental factors on the development of pediatric metabolic syndrome can be the impact of these factors, as air pollutants, on intrauterine growth retardation, low birth weight, and prematurity [15, 16], and the impact of other factors as noise pollution and passive smoking on components of pediatric metabolic syndrome , which in turn can be associated with higher risk of chronic diseases in later life. Furthermore, currently many environmental obesogens are identified; they are classified as chemical simulators of metabolic hormones or brain neurotransmitters [18, 19]. All these mechanisms propose that the systemic responses to long-term exposure to environmental factors could potentially increase the risk for development of the pediatric metabolic syndrome.
Interventions including community involvement can be useful in improving health at individual and public health levels . Prevention and control of modifiable risk factors as air and noise pollution, passive smoking, overweight, and unhealthy lifestyle, along with primordial prevention by good pregnancy care for prevention of low birth weight, encouraging breast feeding, and using healthy complimentary foods during infancy can impact the overall health of children and adolescents as well as the prevention and control of pediatric metabolic syndrome and its treatment modalities.
This special issue is dedicated to increasing the depth of research across all areas of the pediatric metabolic syndrome, and highlights the preventive measures as well as management by nonpharmacological and pharmacological treatment.
Sarah D. de Ferranti
Samuel S. Gidding
- R. Kelishadi, “Childhood overweight, obesity, and the metabolic syndrome in developing countries,” Epidemiologic Reviews, vol. 29, no. 1, pp. 62–76, 2007.
- N. Halfon, P. A. Verhoef, and A. A. Kuo, “Childhood antecedents to adult cardiovascular disease,” Pediatrics in Review, vol. 33, no. 2, pp. 51–61, 2012.
- N. Gupta, K. Goel, P. Shah, and A. Misra, “Childhood obesity in developing countries: epidemiology, determinants, and prevention,” Endocrine Reviews, vol. 33, no. 1, pp. 48–70, 2012.
- M. van Vliet, M. W. Heymans, I. A. von Rosenstiel, D. P. M. Brandjes, J. H. Beijnen, and M. Diamant, “Cardiometabolic risk variables in overweight and obese children: a worldwide comparison,” Cardiovascular Diabetology, vol. 10, article 106, 2011.
- L. Stoner, K. R. Stoner, J. M. Young, and S Fryer, “Preventing a cardiovascular disease epidemic among indigenous populations through lifestyle changes,” International Journal of Preventive Medicine, vol. 3, pp. 230–240, 2012.
- P. T. Bradshaw, K. L. Monda, and J. Stevens, “Metabolic syndrome in healthy obese, overweight, and normal weight individuals: the atherosclerosis risk in communities study,” Obesity. In press.
- V. Nobili, G. Bedogni, R. Berni Canani et al., “The potential role of fatty liver in paediatric metabolic syndrome: a distinct phenotype with high metabolic risk?” Pediatric Obesity. In press.
- S. Gökçe, Z. Atbinici, Z. Aycan, H. G. Çinar, and P. Zorlu, “The relationship between pediatric nonalcoholic fatty liver disease and cardiovascular risk factors and increased risk of atherosclerosis in obese children,” Pediatric Cardiology. In press.
- R. Kelishadi and P. Poursafa, “Obesity and air pollution: global risk factors for pediatric non-alcoholic fatty liver disease,” Hepatitis Monthly, vol. 11, no. 10, pp. 794–802, 2011.
- C. P. Day and O. F. W. James, “Steatohepatitis: a tale of two “Hits“?” Gastroenterology, vol. 114, no. 4 I, pp. 842–845, 1998.
- R. Kelishadi, N. Mirghaffari, P. Poursafa, and S. S. Gidding, “Lifestyle and environmental factors associated with inflammation, oxidative stress and insulin resistance in children,” Atherosclerosis, vol. 203, no. 1, pp. 311–319, 2009.
- R. D. Brook, S. Rajagopalan, C. A. Pope et al., “Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the american heart association,” Circulation, vol. 121, no. 21, pp. 2331–2378, 2010.
- P. Poursafa and R. Kelishadi, “Air pollution, platelet activation and atherosclerosis,” Inflammation and Allergy, vol. 9, no. 5, pp. 387–392, 2010.
- K. D. Sinclair, R. G. Lea, W. D. Rees, and L. E. Young, “The developmental origins of health and disease: current theories and epigenetic mechanisms,” Society of Reproduction and Fertility, vol. 64, supplement, pp. 425–443, 2007.
- G. F. Kerkhof, P. E. Breukhoven, R. W. J. Leunissen, R. H. Willemsen, and A. C. S. Hokken-Koelega, “Does preterm birth influence cardiovascular risk in early adulthood?” Journal of Pediatrics, vol. 161, no. 3, pp. 390–396.e1, 2012.
- R. Kelishadi, P. Poursafa, and K. Keramatian, “Overweight, air and noise pollution: universal risk factors for pediatric pre-hypertension,” Journal of Research in Medical Sciences, vol. 16, no. 9, pp. 1234–1250, 2011.
- F. Grün and B. Blumberg, “Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling,” Endocrinology, vol. 147, no. 6, pp. S50–S55, 2006.
- F. Grün and B. Blumberg, “Minireview: the case for obesogens,” Molecular Endocrinology, vol. 23, no. 8, pp. 1127–1134, 2009.
- Y. Salimi, K. Shahandeh, H. Malekafzali et al., “Is Community-based Participatory Research (CBPR) useful? A systematic review on papers in a decade,” International Journal of Preventive Medicine, vol. 3, pp. 386–393, 2012.